The alpha4beta2alpha5 nicotinic cholinergic receptor in rat brain is resistant to up-regulation by nicotine in vivo.
about
Mammalian nicotinic acetylcholine receptors: from structure to functionNicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug usePaying attention to smell: cholinergic signaling in the olfactory bulbQuantitative analysis of the heteromeric neuronal nicotinic receptors in the rat hippocampusNicotinic receptor subunit alpha5 modifies assembly, up-regulation, and response to pro-inflammatory cytokinesNicotine withdrawal.Cellular, molecular, and genetic substrates underlying the impact of nicotine on learning.The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation.Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice.beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking.Early exposure to nicotine during critical periods of brain development: Mechanisms and consequences.Choline promotes nicotinic receptor alpha4 + beta2 up-regulationChrna4 A529 knock-in mice exhibit altered nicotine sensitivity.86Rb+ efflux mediated by alpha4beta2*-nicotinic acetylcholine receptors with high and low-sensitivity to stimulation by acetylcholine display similar agonist-induced desensitizationAlexa Fluor 546-ArIB[V11L;V16A] is a potent ligand for selectively labeling alpha 7 nicotinic acetylcholine receptorsThe nicotinic acetylcholine receptor alpha5 subunit plays a key role in attention circuitry and accuracy.Acetylcholine receptor (AChR) α5 subunit variant associated with risk for nicotine dependence and lung cancer reduces (α4β2)₂α5 AChR function.RIC-3 differentially modulates α4β2 and α7 nicotinic receptor assembly, expression, and nicotine-induced receptor upregulationIncreased nicotinic acetylcholine receptor protein underlies chronic nicotine-induced up-regulation of nicotinic agonist binding sites in mouse brainThe α5 subunit regulates the expression and function of α4*-containing neuronal nicotinic acetylcholine receptors in the ventral-tegmental areaAn autoradiographic survey of mouse brain nicotinic acetylcholine receptors defined by null mutantsEffects of chronic nicotine on heteromeric neuronal nicotinic receptors in rat primary cultured neurons.Functional characterization of the α5(Asn398) variant associated with risk for nicotine dependence in the α3β4α5 nicotinic receptor.Endogenously expressed muscarinic receptors in HEK293 cells augment up-regulation of stably expressed α4β2 nicotinic receptors.Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses.Upregulation of Nicotinic Acetylcholine Receptor alph4+beta2 through a Ligand-Independent PI3Kbeta Mechanism That Is Enhanced by TNFalpha and the Jak2/p38Mapk Pathways.AT-1001 Is a Partial Agonist with High Affinity and Selectivity at Human and Rat α3β4 Nicotinic Cholinergic Receptors.Function of human α3β4α5 nicotinic acetylcholine receptors is reduced by the α5(D398N) variantNeuronal nicotinic acetylcholine receptors: neuroplastic changes underlying alcohol and nicotine addictionsThe role of alpha5 nicotinic acetylcholine receptors in mouse models of chronic inflammatory and neuropathic pain.The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acute and tonic pain modelsChrna5 genotype determines the long-lasting effects of developmental in vivo nicotine exposure on prefrontal attention circuitryEffects of the specific α4β2 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and miceChronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain.Regulation of α4β2α5 nicotinic acetylcholinergic receptors in rat cerebral cortex in early and late adolescence: Sex differences in response to chronic nicotineAdult and periadolescent rats differ in expression of nicotinic cholinergic receptor subtypes and in the response of these subtypes to chronic nicotine exposure.Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxiaNicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys.Cellular events in nicotine addiction.Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5.
P2860
Q24647069-77D4C16D-BF77-4388-97DE-1BD4ED14C562Q26782271-2C04598B-0404-4C55-A2C0-5B568F6AB132Q27008213-F82C4BC2-76D2-4D90-820A-2186BFDAFA56Q28579460-E3E13C5F-B7B7-49E4-BDEA-564E2DFFCAC0Q28580107-1ECAAC9B-9212-4726-9E1F-F9735749B9CAQ30404700-46D22865-AFA4-420D-A986-41DBF6EDD75CQ30422037-4F501EF7-6689-4070-A314-E1E6B06F2981Q30455930-876F6F1B-1A4C-457B-8AE1-C19F6C88BD0FQ30495752-DA4898FA-A853-4672-8673-65C3D50A9D0DQ33551855-90396D91-FD27-4E24-9531-3B3383292795Q33702097-CA54A620-8E2A-48B4-9583-CA1EE8C66F26Q33924248-80D2DA30-00B1-4C82-B87B-9A3A27200715Q34058860-8033510F-CB75-4688-873B-FCCA9F3F28F5Q34109947-CEA3FA13-0564-411A-A2E8-B842A008B00EQ34113842-84BC125E-F80A-4D41-B70A-8FAE4FBA272EQ34419501-FB6948DA-DB02-4AC4-B8BE-29F76613A740Q34458445-84CEAAC2-30DA-4AB2-9DC7-97C9F2AC4D6EQ34668336-0EAC381C-692F-4D16-99D5-D1901EBD1AABQ34715683-81D18295-4183-4270-87C9-7E445B40EA57Q34837643-C70E51DB-1852-4A8A-B75E-79804F82EC75Q35181919-506BE77C-22C2-44DE-845D-D29716C18F4BQ35209455-07692C69-4478-4657-9F1B-A27ED7930116Q35415808-633F1BE1-93AC-4AB2-873C-DA8426994208Q35562759-346FA5C6-FD48-482B-A572-3988C2CBD113Q35566709-E98A79B4-1B95-4ADF-81EF-666564F25954Q35855997-03D280FE-9E7A-4444-A1D0-9B9EB53653AAQ36077726-9EA26901-C019-4A19-B54F-3F8723CECEC6Q36126982-87D70ADF-C502-48A1-BEC2-236FAE85636BQ36137598-BAEF0800-F6B4-4D34-8BD8-F1D7BFD5DF05Q36144723-AD38C68D-400E-4D44-A9B7-BA67D06E9F32Q36174222-7D30DFD0-94F5-4A88-BC65-2581EF93DB36Q36248758-D0F4BA30-287A-41AA-97D3-CE8CCB5512E9Q36298187-6F0E9532-6367-4B1A-B08F-ADE7620CD529Q36335508-C7C80DEB-BB8F-4F77-AB50-D99C8C0AC318Q36337926-A4BD5A73-5C6C-41C5-B2D0-AC40D3F4A105Q36805246-E05CF024-2407-400C-ADB3-97F5A0C8902AQ37154555-A4DDE79B-491A-4F4D-959F-F23982C17DF0Q37180827-E5913F62-7DBD-4DB9-B945-E3CE9718D116Q37247103-C0DE37B7-01FB-49E0-83E2-D850C3D37B54Q37272338-80514BAD-9F9C-4AB3-B49C-791196B33DB8
P2860
The alpha4beta2alpha5 nicotinic cholinergic receptor in rat brain is resistant to up-regulation by nicotine in vivo.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
The alpha4beta2alpha5 nicotini ...... egulation by nicotine in vivo.
@en
The alpha4beta2alpha5 nicotini ...... egulation by nicotine in vivo.
@nl
type
label
The alpha4beta2alpha5 nicotini ...... egulation by nicotine in vivo.
@en
The alpha4beta2alpha5 nicotini ...... egulation by nicotine in vivo.
@nl
prefLabel
The alpha4beta2alpha5 nicotini ...... egulation by nicotine in vivo.
@en
The alpha4beta2alpha5 nicotini ...... egulation by nicotine in vivo.
@nl
P2093
P2860
P1476
The alpha4beta2alpha5 nicotini ...... egulation by nicotine in vivo.
@en
P2093
Barry B Wolfe
Danyan Mao
David C Perry
Kenneth J Kellar
Robert P Yasuda
P2860
P304
P356
10.1111/J.1471-4159.2007.05011.X
P407
P577
2007-10-24T00:00:00Z